Anthropic Acquires Mithril Medicine to Expand Rare-Disease Research

Anthropic has acquired Mithril Medicine, a one-person biotech developing treatments for two rare forms of muscular dystrophy, and brought its founder, Cody Tranbarger, into the company. Before the deal, Tranbarger used Claude to coordinate experiments and operations across 11 external laboratories; one candidate reached promising results in mice in less than 18 months.